U‐Ging Lo

1.2k total citations
24 papers, 770 citations indexed

About

U‐Ging Lo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, U‐Ging Lo has authored 24 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in U‐Ging Lo's work include Prostate Cancer Treatment and Research (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). U‐Ging Lo is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). U‐Ging Lo collaborates with scholars based in United States, Taiwan and China. U‐Ging Lo's co-authors include Jer‐Tsong Hsieh, Chih‐Ho Lai, Ho Lin, Cheng‐Fan Lee, Chun‐Jung Lin, Ming‐Shyue Lee, Yuan Chen, Rey-Chen Pong, Eun-Jin Yun and Diane Yang and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

U‐Ging Lo

24 papers receiving 770 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
U‐Ging Lo 409 192 192 168 93 24 770
Ting Huang 421 1.0× 134 0.7× 257 1.3× 178 1.1× 127 1.4× 40 900
Jie Zhu 555 1.4× 161 0.8× 265 1.4× 159 0.9× 124 1.3× 55 946
Xuefeng Xia 363 0.9× 118 0.6× 257 1.3× 192 1.1× 145 1.6× 33 777
Mengya Zhong 329 0.8× 115 0.6× 137 0.7× 118 0.7× 65 0.7× 36 572
Yong Fang 566 1.4× 171 0.9× 269 1.4× 118 0.7× 77 0.8× 50 953
Yariswamy Manjunath 415 1.0× 104 0.5× 237 1.2× 278 1.7× 170 1.8× 41 935
Chao Su 571 1.4× 144 0.8× 224 1.2× 206 1.2× 193 2.1× 44 976
Ezia Bello 411 1.0× 223 1.2× 140 0.7× 287 1.7× 59 0.6× 36 922
Lizhong Liu 542 1.3× 96 0.5× 267 1.4× 142 0.8× 80 0.9× 15 850
Vanessa Moreno 360 0.9× 77 0.4× 116 0.6× 120 0.7× 68 0.7× 10 668

Countries citing papers authored by U‐Ging Lo

Since Specialization
Citations

This map shows the geographic impact of U‐Ging Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U‐Ging Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U‐Ging Lo more than expected).

Fields of papers citing papers by U‐Ging Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U‐Ging Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U‐Ging Lo. The network helps show where U‐Ging Lo may publish in the future.

Co-authorship network of co-authors of U‐Ging Lo

This figure shows the co-authorship network connecting the top 25 collaborators of U‐Ging Lo. A scholar is included among the top collaborators of U‐Ging Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U‐Ging Lo. U‐Ging Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yuan, U‐Ging Lo, Rey-Chen Pong, et al.. (2024). SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade. Cell Death and Disease. 15(9). 678–678. 8 indexed citations
2.
Lo, U‐Ging, Yu‐An Chen, Junjie Cen, et al.. (2022). The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer. Clinical and Translational Medicine. 12(8). e978–e978. 24 indexed citations
3.
Yuan, Chen, Hui-Yu Wu, Yu‐Fang Chang, et al.. (2021). Bacterial Genotoxin-Coated Nanoparticles for Radiotherapy Sensitization in Prostate Cancer. Biomedicines. 9(2). 151–151. 11 indexed citations
4.
Joseph, Diya B., Douglas W. Strand, U‐Ging Lo, et al.. (2020). The Roles of ZnT1 and ZnT4 in Glucose-Stimulated Zinc Secretion in Prostate Epithelial Cells. Molecular Imaging and Biology. 23(2). 230–240. 11 indexed citations
5.
Lee, Cheng‐Fan, Andrew Dang, Rey-Chen Pong, et al.. (2019). Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase. Oncogene. 38(28). 5580–5598. 33 indexed citations
6.
Lin, Chun‐Jung, Eun-Jin Yun, U‐Ging Lo, et al.. (2019). The paracrine induction of prostate cancer progression by caveolin-1. Cell Death and Disease. 10(11). 834–834. 51 indexed citations
7.
Huang, Jun, U‐Ging Lo, Shiqi Wu, et al.. (2019). The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression. Cell Death and Disease. 10(6). 437–437. 24 indexed citations
8.
Chen, Yuan, David T.W. Tzeng, Yi‐Ping Huang, et al.. (2018). Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers. 11(1). 34–34. 45 indexed citations
9.
Hsieh, Jer‐Tsong, Chun‐Jung Lin, & U‐Ging Lo. (2018). The regulatory pathways leading to stem-like cells underlie prostate cancer progression. Asian Journal of Andrology. 21(3). 233–233. 19 indexed citations
10.
Lo, U‐Ging, Rey-Chen Pong, Diane Yang, et al.. (2018). IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing. Cancer Research. 79(6). 1098–1112. 67 indexed citations
11.
Lin, Hwai‐Jeng, Chia‐Der Lin, Yuan Chen, et al.. (2017). Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy. Frontiers in Cellular and Infection Microbiology. 7. 223–223. 18 indexed citations
12.
Chen, Yuan, U‐Ging Lo, Chun‐Jung Lin, et al.. (2017). Sensitization of Radioresistant Prostate Cancer Cells by Resveratrol Isolated from Arachis hypogaea Stems. PLoS ONE. 12(1). e0169204–e0169204. 32 indexed citations
13.
Wang, Bin, U‐Ging Lo, Kaijie Wu, et al.. (2017). Developing new targeting strategy for androgen receptor variants in castration resistant prostate cancer. International Journal of Cancer. 141(10). 2121–2130. 26 indexed citations
14.
Chen, Yuan, Chun‐Jung Lin, Hwai‐Jeng Lin, et al.. (2016). Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin. Frontiers in Cellular and Infection Microbiology. 6. 9–9. 36 indexed citations
15.
Yun, Eun-Jin, U‐Ging Lo, & Jer‐Tsong Hsieh. (2016). The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges. Asian journal of urology. 3(4). 203–210. 16 indexed citations
16.
Huang, Wenying, Jia-Ni Lin, Jer‐Tsong Hsieh, et al.. (2016). Nanoparticle Targeting CD44-Positive Cancer Cells for Site-Specific Drug Delivery in Prostate Cancer Therapy. ACS Applied Materials & Interfaces. 8(45). 30722–30734. 77 indexed citations
17.
Lin, Chun‐Jung, Lii-Tzu Wu, U‐Ging Lo, et al.. (2015). Impact of cholesterol on disease progression. Biomedicine. 5(2). 7–7. 35 indexed citations
18.
Lo, U‐Ging, Rey-Chen Pong, Diane Yang, et al.. (2015). Abstract 2873: Identification of a new mechanism of microRNA turnover from miR-106a-363 cluster leading to epithelial-to-mesenchymal transition in prostate cancer. Cancer Research. 75(15_Supplement). 2873–2873. 1 indexed citations
19.
Lo, U‐Ging, Diane Yang, & Jer‐Tsong Hsieh. (2013). The role of microRNAs in prostate cancer progression.. PubMed. 2(3). 228–41. 25 indexed citations
20.
Soundarapandian, Mangala M., Vimal Selvaraj, U‐Ging Lo, et al.. (2011). Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination. Scientific Reports. 1(1). 2–2. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting Huang Breakdown of academic impact, for papers by Jie Zhu Breakdown of academic impact, for papers by Xuefeng Xia Breakdown of academic impact, for papers by Mengya Zhong Breakdown of academic impact, for papers by Yong Fang Breakdown of academic impact, for papers by Yariswamy Manjunath Breakdown of academic impact, for papers by Chao Su Breakdown of academic impact, for papers by Ezia Bello Breakdown of academic impact, for papers by Lizhong Liu Breakdown of academic impact, for papers by Vanessa Moreno
Rankless by CCL
2026